Clinical trial
Risperidone vs. Paroxetine for Panic Attacks
NCT00206765 · Beth Israel Medical Center, Other · Terminated
Key facts
| NCT number | NCT00206765 |
|---|---|
| Title | Risperidone vs. Paroxetine for Panic Attacks |
| Official title | A Single-blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks |
| Lead sponsor | Beth Israel Medical Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder With Panic Attacks, Panic Disorder |
| Intervention type | Drug |
| Interventions | Risperidone, Paroxetine |
| Enrollment | 90 |
| Start date | Jan 1, 2003 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: